• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

Oxidative stress is a potent link between hepatocyte damage and HSC activation in hepatic fibrosis

Research Project

Project/Area Number 11670509
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTokushima University

Principal Investigator

SHIMIZU Ichiro  Tokushima University School of Medicine Instructor, 医学部・附属病院, 講師 (10178965)

Project Period (FY) 1999 – 2000
KeywordsOxidative stress / Hepatic fibrosis / Lipid peroxidation / Hepatic stellate cell / Hepatocyte / SOD / MDA / Glutathione peroxidase
Research Abstract

Oxidative stress has a causative role in the development of hepatic fibrosis, or the deposition of extracellular matrix (ECM). Hepatic stellate cells (HSCs) functions as the production of ECM components in the injured liver. In addition, NF-κB is a key transcription factor that induces multiple genes in response to inflammation, infections, and oxidative stress. Signals that induce NF-κB activity cause the dissociation and subsequent degradation of IκB-α protein. Whereas many cells have their own unique enzymatic defense systems against oxidative stress, including the production of superoxide dismutase (SOD) and glutathione peroxidase (GPx), which play a critical role in protecting the cell from oxygen-derived free radicals and other reactive oxygen species. In this study, the fibrotic livers of the DMN model showed the increased hepatic levels of collagen and malondialdehyde (MDA), a product of lipid peroxidation, and reduced hepatic levels of SOD and GPx In addition, our study demonstrated that cultured rat hepatocytes respond robustly to oxidative stress with a time-dependent increase in degradation of IκB-α and subsequent NF-κB activation as well as in secretion of MDA and LDH into the culture medium. HSCs were found to be activated NF-κB along with the IκB-α degradation and be increased α-SMA expression and collagen production by MDA supplementation. These findings suggest that paracrine stimuli derived from hepatocytes undergoing oxidative stress induce HSC activation, at least in part, through the degradation of IκB-α and subsequent NF-κB activation.

  • Research Products

    (32 results)

All Other

All Publications (32 results)

  • [Publications] Shimizu I, et al.: "Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats."Hepatology. 29(1). 149-160 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yasuda M,Shimizu I, et al.: "Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats."Hepatology. 29(3). 719-727 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I, et al.: "Inhibitory effect of estradiol on activation of rat hepatic stellate cells in vivo and in vitro."Gut. 44(1). 127-136 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I: "Sho-saiko-to : Japanese herbal medicine for protection against hepatic fibrosis and carcinoma."J Gastroenterol Hepatol. 15(Suppl 1). D84-D90 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I, et al.: "Serum amino terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following interferon-α therapy."J Gastroenterol Hepatol. 16(2). 196-201 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I, et al.: "Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction"Intern Med. 40(2)(in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Omoya T, Shimizu I, et al.: "Effects of idoxifene and estradiol on NF-κB activation in cultured rat hepatocytes undergoing oxidative stress."Liver. 21(2)(in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎 他: "ビタミンAの肝線維化抑制作用."薬理と治療. 27(Suppl.3). S847-S848 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎 他: "脂質過酸化反応と肝線維化."岡山医誌. 111(3-8). 131-132 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎: "肝炎ウイルスと肝癌."医薬ジャーナル. 35(6). 77-82 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 伊東進,清水一郎 他: "アルコール肝障害と酸化ストレス."消火器科. 29(6). 695-700 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎: "肝硬変・肝癌における性差."医学のあゆみ. 195(6). 417-421 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎,伊東進: "肝線維化とoxidative stress."肝臓. 41(8). 623-624 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Zhou Yajun,清水一郎 他: "選択的エストロゲン受容体モジュレーター、idoxifeneの抗酸化作用、抗アポトーシス作用と肝線維化抑制作用."医学と薬学. 45(1). 72-75 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I, et al.: "Antioxidant and anti-apoptotic activities of a tissue-specific selective estrogen receptor modulator, idoxifene, in rat fibrotic liver and in cultured rat hepatocytes. In ; Gastroenterology and Hepatology : Millennium 2000. Ed.Asakura H."Springer-Verlag Tokyo(in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 清水一郎 他: "女性ホルモン・エストラジオールの抗酸化作用と肝線維化抑制作用.性差医学・No.6(坂本正一,折茂肇,玉田太朗,熊本悦明,新井康允,鳥羽研二編集)、"メジカルセンス、東京. 120(95-99) (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimizu I, Ma Y-R, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S: "Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats."Hepatology. 29(1). 149-160 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yasuda M, Shimizu I, Shiba M, Ito S: "Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats."Hepatology. 29(3). 719-727 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma Y-R, Horie T, Liu F, Ito S: "Inhibitory effect of estradiol on activation of rat hepatic stellate cells in vivo and in vitro."Gut. 44(1). 127-136 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I : Sho-saiko-to: "Japanese herbal medicine for protection against hepatic fibrosis and carcinoma."J Gastroenterol Hepatol. 15 (Suppl 1). D84-D90 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Omoya T, Takaoka T, Wada S, Wada H, Taoka M, Hayashi H, Hayashi S, Honda H, Sano N, Ito S: "Serum amino terminal propeptide of type III procollagen and 7S domain of type IV collagen correlate with hepatic iron concentration in patients with chronic hepatitis C following interferon-α therapy."J Gastroenterol Hepatol. 16(2). 196-201 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Shono M, Omoya T, Kondo Y, Tadatsu M, Okita Y, Okamura S, Honda H, Sano N, Ito S: "Estrogen therapy in a male patient with chronic hepatitis C and irradiation-induced testicular dysfunction."Intern Med. 40(2)(in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, Itonaga M, Honda H, Nomura M, Ito S: "Effects of idoxifene and estradiol on NF-κB activation in cultured rat hepatocytes undergoing oxidative stress."Liver. 21(2)(in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Mizobuchi Y, Omoya T, Liu Y, Hiasa A, Ichikawa S, Taoka S, Sogabe M, Shibata H, Honda H, Ito S: "Vitamin A reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum."Jpn Pharmacol Ther. 27 (Suppl.3). S847-S848 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Omoya T, Liu Y, Hiasa A, Tada Y, Muguruma N, Shibata H, Honda H, Ito S, Shono M: "Hepatic fibrosis and lipid peroxidation."J Okayama Med. 111 (3-8). 131-132 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I: "Hepatitis virus and hepatocarcinogenesis."Med J. 35 (6). 77-82 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ito S, Shimizu I, Honda H: "Oxidative stress and alcoholic liver injury."Gastroenterology (Japan). 29 (6). 695-700 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I: "Sex-associated differences in the progression to cirrhosis and hepatocellular carcinoma."IGAKU-NO-AYUMI. 195 (6). 417-421 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Ito S: "Hepatic fibrosis and oxidative stress."Liver (Japan). 41(8). 623-624 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Zhou Y, Shimizu I, Inoue H, Omoya T, Itonaga M, Lu G, Okamura Y, Honda H, Ito S: "Antioxidant, anti-apoptotic, and fibrosuppressant activities of a tissue-specific selective estrogen receptor modulator, idoxifene."Jpn J Med Pharm Sci. 45 (1). 72-75 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Omoya T, Zhou Y, Itonaga M, Inoue H, Lu G, Okamura Y, Shono M, Honda H, Ito S: "Antioxidant and anti-apoptotic activities of a tissue-specific selective estrogen receptor modulator, idoxifene, in rat fibrotic liver and in cultured rat hepatocytes."In ; Gastroenterology and Hepatology : Millennium 2000. Ed. Asakura H, Springer-Verlag Tokyo. 350-355 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimizu I, Omoya T, Liu Y, Zhou Y, Toyoda T, Inayama K, Kusaka I, Shibata H, Honda H, Nomura M, Ito S: "Estradiol functions as an antioxidant and fibrosuppressant in the liver."In : Sex Difference and Similarity No.6. Eds. Sakamoto S, Orimo S, Tamada T, Kumamoto E, Arai Y, Toba K, Medicalsense, Tokyo. 95-99 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi